VANTAGE is a genomics core laboratory consolidation initiated by an $8.6 million ARRA funded NIH grant award to Vanderbilt University Medical Center, with an overall goal of creating a new collaborative [VANTAGE] shared resource that accelerates discovery in genome sciences and personalized medicine, providing state-of-the art research shared resource facilities and technology.
The NIH grant provided funds for complete modernization of 12,505 Net Square Feet of aging laboratory space in Medical Center North, and for new cutting edge scientific equipment now utilized by the core labs located in the newly renovated space. Renovation was completed in May 2012, and the core labs (see below) are now in full service mode in their new laboratories.
VANTAGE is a one-stop genomics research resource, including: Illumina genotyping, DNA extraction and banking, Affymetrix–based genotyping and expression microarrays, Sanger sequencing and Next Generation Sequencing (NGS) among many other specialized services. These activities are now part of an overall structure that takes full advantage of their new physical co-location together with the Flow Cytometry Shared Resource in VANTAGE.
Scientific Director: James Crowe, MD
Associate Director, Immunogenetics: Simon Mallal, MBBS
Technical Director, Sequencing, High-Throughput Genotyping and Expression Services: Holli Dilks, PhD
Manager, Biobanking Services and Low-Throughput Genotyping: Cara Sutcliffe, MS
Phone: (615) 936-2744
Faculty Advisory Committee Members (2014-2015):
Advisory Committee Meetings:
May 19, 2014
This project is supported by NIH/NCRR Grant Number G20 RR030956.Reporter article: http://www.mc.vanderbilt.edu/reporter/index.html?ID=8577
Reporter article: http://www.mc.vanderbilt.edu/reporter/index.html?ID=12800